The Fragile X Treatment Pipeline: Current and Emerging Clinical Trials

Join FRAXA Research Foundation for a community webinar on the Fragile X treatment pipeline, featuring leading Fragile X clinical researchers Elizabeth M. Berry-Kravis, MD, PhD, and Craig Erickson, MD.

This session will explain clinical trials which are, or soon will be, accepting participants with Fragile X syndrome. Programs from Spinogenix, Mirum, Servier, and others will be covered. Drs. Berry-Kravis and Erickson will discuss the science behind these therapeutic approaches, where each program stands today, and what families may want to know about eligibility, recruitment, and trial participation.

A live Q&A session will follow the presentations.

For individuals with Fragile X syndrome, families, caregivers, clinicians, and advocates, this webinar offers a practical, forward-looking look at the work underway today and how it fits into the broader effort to develop effective treatments.